The leptin/adiponectin ratio: potential implications for peritoneal dialysis.

Area of Science:

• Endocrinology
• Nephrology
• Cardiovascular Science

Background:

• Leptin and adiponectin are key adipokines influencing atherosclerosis.
• The plasma leptin/adiponectin ratio is a potential marker for cardiovascular risk.
• Peritoneal dialysis (PD) patients exhibit an elevated leptin/adiponectin ratio, indicating heightened cardiovascular risk.

Purpose of the Study:

• To investigate the impact of peritoneal dialysis (PD) fluid components, particularly glucose, on adipokine production.
• To explore how different PD fluid compositions affect the leptin/adiponectin ratio in PD patients.

Main Methods:

• In vitro studies using 3T3-L1 adipocytes exposed to various PD fluids (glucose-based, amino-acid-based, icodextrin-based).
• In vivo analysis of plasma leptin levels in PD patients after a single PD fluid dwell.
• Longitudinal assessment of the plasma leptin/adiponectin ratio in PD patients on different glucose load regimens.

Main Results:

• Glucose-based PD fluids significantly increased leptin secretion and decreased adiponectin secretion in vitro.
• Higher glucose concentrations in PD fluids correlated with increased leptin secretion.
• A reduction in glucose load in PD regimens was associated with improved plasma leptin/adiponectin ratio in patients.

Conclusions:

• Glucose-based PD fluids negatively impact the adipokine balance, potentially increasing cardiovascular risk in PD patients.
• Glucose-free or glucose-sparing PD regimens show promise in improving the adipokine profile.
• Further clinical studies are required to establish the cardiovascular benefits of glucose-sparing PD strategies.